Back
HFA Premium Access

Impact of dapagliflozin in quality of life of patients with aortic stenosis undergoing transcatheter aortic valve implantation

Session: Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease
Topic: Aortic Valve Intervention
Speaker: Doctor C. Bonanad Lozano (Valencia, ES)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Clara Bonanad Lozano

Instituto de Investigacion Sanitaria INCLIVA, Valencia (Spain)
4 presentations
1 follower

6 more presentations in this session

Discussant panel

Access
Like
Thumbnail

Safety and tolerability of a 5 mg starting dose of vericiguat among patients with heart failure: the VELOCITY study

Speaker: Professor S. Greene (Durham, US)

Access
Slides
Video
Like
Thumbnail

Cardiopulmonary exercise testing as a novel endpoint in clinical trials on ATTR amyloid cardiomyopathy

Speaker: Doctor A. Porcari (London, GB)

Access
Slides
Video
Like
Thumbnail

Efficacy and safety of aficamten in patients with obstructive hypertrophic cardiomyopathy and mild symptoms

Speaker: Professor I. Olivotto (Florence, IT)

Access
Slides
Video
Like
Thumbnail

Pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2

Speaker: Doctor J. Nunez Villota (Valencia, ES)

Access
Slides
Video
Like
Thumbnail

Access the full session

Late-breaking science in heart failure, cardiomyopathies, pulmonary hypertension and valvular heart disease

Speakers: Doctor C. Bonanad Lozano, Professor S. Greene, Doctor A. Porcari, Professor I. Olivotto, Doctor J. Nunez Villota
Access
Video
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources